Fundraising Fox
Impelpharma
Founded 2008 · 42 employees on LinkedIn · 3 known investors
Find your way into Impelpharma
Sign up to see every warm intro you have to Impelpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Impelpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Impel Pharmaceuticals develops therapies for patients using its drug delivery technology and expertise with small and large molecules. The company pursues partnerships, collaborations, and licensing opportunities to expand the therapeutic applications of its technology.
Investors · 3
Cowles Ventureslisted by Cowles VenturesSpokane · $250K – $1M
How we know: Cowles Ventures's portfolio page · Not right? Tell us
venBio Partnerslisted by venBio PartnersSan Francisco
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Impelpharma do?
- Impel Pharmaceuticals develops therapies for patients using its drug delivery technology and expertise with small and large molecules. The company pursues partnerships, collaborations, and licensing opportunities to expand the therapeutic applications of its technology.
- Who are Impelpharma's investors?
- Impelpharma's investors include Cowles Ventures, Norwest Venture Partners, venBio Partners.